FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL)

被引：0
作者：
Nuzhat N. Kabir
Lars Rönnstrand
Julhash U. Kazi
机构：
[1] KN Biomedical Research Institute,Laboratory of Computational Biochemistry
[2] Lund University,Experimental Clinical Chemistry, Department of Laboratory Medicine
来源：
Medical Oncology | 2013年 / 30卷
关键词：
Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Lymphoblastic Leukemia; Acute Myeloid Leukemia Patient; Common Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   FLT3 inhibitors in acute myeloid leukemia [J].
el-Shami, Khaled ;
Stone, Richard M. ;
Smith, B. Douglas .
EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (02) :153-160
[32]   THE ROLE OF FLT3-ITD AND CEBPA MUTATIONS ON PROGNOSIS OF ACUTE LYMPHOBLASTIC LEUKEMIA IN TURKISH PATIENTS [J].
Uluca, I. ;
Soker, M. ;
Ayyildiz, M. ;
Yurt, M. ;
Sen, V. ;
Yel, S. ;
Coskun, S. ;
Tan, I. ;
Sahin, C. .
LEUKEMIA RESEARCH, 2014, 38 :S53-S53
[33]   Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia [J].
Song, Moo-Kon ;
Park, Byeong-Bae ;
Uhm, Ji-Eun .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
[34]   Clinical relevance of FLT3 receptor protein expression in Indian patients with acute leukemia [J].
Vora, Hemangini H. ;
Shukla, Shilin N. ;
Brahambhatt, Birwa V. ;
Mehta, Shalvi H. ;
Patel, Nupur A. ;
Parikh, Sonia K. ;
Shah, Kruti N. ;
Shah, Pankaj M. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (04) :306-319
[35]   Differential signaling of Flt3 activating mutations in acute myeloid leukemia: a working model [J].
Chan, Perry M. .
PROTEIN & CELL, 2011, 2 (02) :108-115
[36]   FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development [J].
Kiyoi, Hitoshi ;
Kawashima, Naomi ;
Ishikawa, Yuichi .
CANCER SCIENCE, 2020, 111 (02) :312-322
[37]   Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia [J].
Wang, Eunice S. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) :154-162
[38]   DETERMINATION OF FLT3 MUTATIONS AND MINIMAL RESIDUAL DEASEASE MONITORING IN FLT3-POSITIVE ACUTE MYELOID LEUKEMIA [J].
V. Sidorova, Y. ;
Severina, N. A. ;
Biderman, B., V ;
Risinskaya, N., V ;
Fevraleva, I. S. ;
Kostromina, M. A. ;
Starodub, S. M. ;
Kashlakova, A. I. ;
Lukyanova, I. A. ;
Sudarikov, A. B. ;
Parovichnikova, E. N. .
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2025, 70 (01) :8-26
[39]   The Impact of Flt3 Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis [J].
Picharski, Gledson L. ;
Andrade, Diancarlos P. ;
Fabro, Ana Luiza M. R. ;
Lenzi, Luana ;
Tonin, Fernanda S. ;
Ribeiro, Raul C. ;
Figueiredo, Bonald C. .
CANCERS, 2019, 11 (09)
[40]   FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs [J].
Ahn, Jae-Sook ;
Kim, Hyeoung-Joon .
BLOOD RESEARCH, 2022, 57 :32-36
12345